Literature DB >> 8404785

Comparative effects of prolonged intake of highly purified fish oils as ethyl ester or triglyceride on lipids, haemostasis and platelet function in normolipaemic men.

J B Hansen1, J O Olsen, L Wilsgård, V Lyngmo, B Svensson.   

Abstract

Conflicting results have been reported about the absorption of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) either as an ethyl ester (EE) or in a triglyceride (TG) formula. We decided to conduct a randomized double-blind study to compare the effects of EE and TG on plasma fatty acids, platelet function and haemostasis. Thirty-one healthy normolipaemic men were allocated to receive fish oil concentrate either as EE or TG with equal amounts of EPA (2.2 g and 2.2 g, respectively) and DHA (1.2 g and 1.4 g, respectively) or placebo daily for 7 weeks. Total cholesterol and the triglyceride level were not influenced differently by the two compounds. Repeated measurement ANOVA revealed a difference between TG and EE regarding incorporation of arachidonic acid (P = 0.034) and EPA (P = 0.007) into plasma cholesteryl esters. A discrimination not observed within plasma phospholipids. Both formulas had equal inhibitory effects on collagen-induced platelet aggregation and thromboxane B2 (TxB2) production in whole blood. Fibrinogen decreased 16% in EE (P = 0.034) and 12% in the placebo group (P = 0.11), but variance analysis of delta change during intervention did not indicate differences between groups. It is concluded that TG and EE fish oils are well incorporated into plasma lipids and have similarly beneficial influence one platelet function in men.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404785

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  12 in total

Review 1.  n-3 fatty acids and lipoproteins: comparison of results from human and animal studies.

Authors:  W S Harris
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

2.  Overview of omega-3 Fatty Acid therapies.

Authors:  J Chris Bradberry; Daniel E Hilleman
Journal:  P T       Date:  2013-11

3.  Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia.

Authors:  J B Hansen; S Grimsgaard; H Nilsen; A Nordøy; K H Bønaa
Journal:  Lipids       Date:  1998-02       Impact factor: 1.880

Review 4.  Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia.

Authors:  Sheridan M Hoy; Gillian M Keating
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

5.  Spectral profiles of commercial omega-3 supplements: an exploratory analysis by ATR-FTIR and 1H NMR.

Authors:  Thiago I B Lopes; Elba S Pereira; Deisy Dos S Freitas; Samuel L Oliveira; Glaucia B Alcantara
Journal:  J Food Sci Technol       Date:  2019-11-13       Impact factor: 2.701

6.  Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease.

Authors:  Giacomo Levantesi; Maria Giuseppina Silletta; Roberto Marchioli
Journal:  J Multidiscip Healthc       Date:  2010-07-07

7.  Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil.

Authors:  Jan Philipp Schuchardt; Inga Schneider; Henrike Meyer; Juliane Neubronner; Clemens von Schacky; Andreas Hahn
Journal:  Lipids Health Dis       Date:  2011-08-22       Impact factor: 3.876

8.  Significant inverse association of marine n-3 fatty acids with plasma fibrinogen levels in Japanese in Japan but not in whites or Japanese Americans.

Authors:  L J Hassen; H Ueshima; J D Curb; J Choo; S Lee; K Masaki; T Kadowaki; C Shin; R W Evans; T B Seto; A Fujiyoshi; B J Willcox; K Sutton-Tyrrell; A Kadota; A El-Saed; K Miura; L H Kuller; A Sekikawa
Journal:  Eur J Clin Nutr       Date:  2011-09-07       Impact factor: 4.016

Review 9.  A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels.

Authors:  Clemens von Schacky
Journal:  Vasc Health Risk Manag       Date:  2006

10.  Effect of Nutritionally Relevant Doses of Long-Chain N-3 Pufa on Lipid Status, Oxidative Stress and Inflammatory Markers in an Average Middle-Aged Serbian Population.

Authors:  Ivana Đuričić; Jelena Kotur-Stevuljević; Milica Miljković; Mirko Kerkez; Vladimir Đorđević; Ljubomir Đurašić; Slađana Šobajić
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.